Invesaro

Stocks Health care BLCO

NYSE · Health care

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp brought in $5.3B of revenue over the twelve months to June 30, 2026, up 8.9% from a year earlier. It posted a net loss of $171M. In fiscal 2025 capital spending exceeded operating cash flow by $66M. At June 30, 2026 it held $367M in cash against $5.1B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 29, 2026.

Price
$16.86
+0.36% on the day · September 25, 2026
52-week range $13.77 to $18.92
Market cap
$6B
Revenue (last 12 months)
$5.3B
+8.9% year on year
Net margin
-3.2%

What Bausch & Lomb Corp does

Bausch & Lomb Corp is registered with the SEC under industry code SIC 3851 (Ophthalmic Goods). Its shares trade on NYSE under the ticker BLCO.

Revenue and profit by year

Revenue
FY20: $3.4B $3.4B FY20FY22: $3.8B $3.8B FY22FY22: $3.8B $3.8B FY22FY23: $4.1B $4.1B FY23FY24: $4.8B $4.8B FY24FY25: $5.1B $5.1B FY25
Net income
FY20: -$18M -$18M FY20FY22: $182M $182M FY22FY22: $6M $6M FY22FY23: -$260M -$260M FY23FY24: -$317M -$317M FY24FY25: -$360M -$360M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$5.1B$113M-$360M-$1.02-$66M
2024$4.8B$162M-$317M-$0.90-$59M
2023$4.1B$130M-$260M-$0.74-$198M
2022$3.8B$207M$6M$0.02$170M
2022$3.8B$329M$182M$0.52$680M
2020$3.4B$260M-$18M-$0.05$269M

Latest SEC filings

What Bausch & Lomb Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 12, 2026
    Executive or director change 8-K/A
  2. August 6, 2026
    Executive or director change 8-K
  3. July 29, 2026
    Quarterly report 10-Q · period to June 30, 2026
  4. July 29, 2026
    Quarterly results 8-K
  5. June 1, 2026
    Conflict minerals disclosure SD
  6. May 20, 2026
    Shareholder vote results 8-K
  7. April 29, 2026
    Quarterly report 10-Q · period to March 31, 2026
  8. April 29, 2026
    Quarterly results 8-K
  9. April 10, 2026
    Annual report to shareholders ARS
  10. April 10, 2026
    Proxy statement DEF 14A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 14, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about BLCO

What does Bausch & Lomb Corp do?

Bausch & Lomb Corp is registered with the SEC under industry code SIC 3851 (Ophthalmic Goods). Its shares trade on NYSE under the ticker BLCO.

Is Bausch & Lomb Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $171M on revenue of $5.3B.

How much revenue does Bausch & Lomb Corp make?

Over the twelve months to June 30, 2026 Bausch & Lomb Corp reported revenue of $5.3B. That is 8.9% more than a year earlier.

When did Bausch & Lomb Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 29, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 14, 2026.

Similar companies

ALC
Alcon Inc
COO
Cooper Companies, Inc.
EYE
National Vision Holdings, Inc.
WRBY
Warby Parker Inc.
STAA
Staar Surgical Co
RXST
RxSight, Inc.

Follow BLCO

Get an email when Bausch & Lomb Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow BLCO: get an email when it files

Where the numbers come from

Financial figures are the values Bausch & Lomb Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.